DORIS CUDJOE: Open Payments
NPI 1669098356 · GRAND PRAIRIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,136 in 104 payments from 14 companies in 2025. Trend: 2023 $1,774 · 2024 $1,853 · 2025 $3,136
Food & beverage: $3,136
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $478 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $468 |
| Otsuka America Pharmaceutical, Inc. | 18 | $418 |
| Teva Pharmaceuticals USA, Inc. | 11 | $311 |
| E.R. Squibb & Sons, L.L.C. | 13 | $298 |
| Vanda Pharmaceuticals Inc. | 7 | $264 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $225 |
| ABBVIE INC. | 12 | $222 |
| Lundbeck LLC | 8 | $153 |
| Alkermes, Inc. | 1 | $122 |
Products named: REXULTI, Auvelity, CAPLYTA, COBENFY, FANAPT, TRINTELLIX, VRAYLAR, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
